A randomized phase III trial of biochemotherapy versus interferon-α-2b for adjuvant therapy in patients at high risk for melanoma recurrence.

Autor: Kim, Kevin B., Legha, Sewa S., Gonzalez, Rene, Anderson, Clay M., Johnson, Marcella M., Liu, Ping, Papadopoulos, Nicholas E., Eton, Omar, Plager, Carl, Buzaid, Antonio C., Prieto, Victor G., Hwu, Wen-Jen, Frost, Angela M., Alvarado, Gladys, Hwu, Patrick, Ross, Merrick I., Gershenwald, Jeffrey E., Lee, Jeffrey E., Mansfield, Paul F., Benjamin, Robert S.
Zdroj: Melanoma Research; Feb2009, Vol. 19 Issue 1, p42-49, 8p
Databáze: Complementary Index